Back
Akari Therapeutics PLC Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
AKTX
Akari Therapeutics PLC
Last Price:
$0.98
Seasonality Move:
-8.16%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and AKTX is experiencing selling pressure, which indicates risk of future bearish movement.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.98 | Buy |
| 20-day SMA: | 1.1 | Sell |
| 50-day SMA: | 1.74 | Sell |
| 200-day SMA: | 2.4 | Sell |
| 8-day EMA: | 0.99 | Sell |
| 20-day EMA: | 1.16 | Sell |
| 50-day EMA: | 1.67 | Sell |
| 200-day EMA: | 2.56 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 32.84 | Sell |
| Chaikin Money Flow: | -31247 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.96 - 1.32) | Sell |
| Bollinger Bands (100): | (1.6 - 3.46) | Sell |
Akari Therapeutics PLC Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 0.98 while AKTX 8-day simple moving average is 0.98, which is a Buy signal.
-
The stock price of AKTX is 0.98 while Akari Therapeutics PLC 20-day SMA is 1.10, which makes it a Sell.
-
Akari Therapeutics PLC 50-day simple moving average is 1.74 while AKTX share price is 0.98, making it a Sell technically.
-
AKTX stock price is 0.98 and Akari Therapeutics PLC 200-day simple moving average is 2.40, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Sell
28
Akari Therapeutics PLC (AKTX)
is a Sell
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a SellThe current Akari Therapeutics PLC [AKTX] share price is $0.98. The Score for AKTX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
24.3M
Price in USD:
0.98
Share Volume:
31.2K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
0.90
Sell
28
Akari Therapeutics PLC (AKTX)
is a Sell
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?The Akari Therapeutics PLC stock price is 0.98 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is overvalued.
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 0.98 while AKTX 8-day exponential moving average is 0.99, which is a Sell signal.
-
The stock price of AKTX is 0.98 while Akari Therapeutics PLC 20-day EMA is 1.16, which makes it a Sell.
-
Akari Therapeutics PLC 50-day exponential moving average is 1.67 while AKTX share price is 0.98, making it a Sell technically.
-
AKTX stock price is 0.98 and Akari Therapeutics PLC 200-day simple moving average is 2.56, creating a Sell signal.
Fundamental Analysis of Akari Therapeutics PLC
Is Akari Therapeutics PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Akari Therapeutics PLC is a Sell
-
Akari Therapeutics PLC Relative Strength Index (RSI) is 32.84, which suggest Akari Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Akari Therapeutics PLC is (0.96 - 1.32), which suggest Akari Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Akari Therapeutics PLC is (1.6 - 3.46), which suggest Akari Therapeutics PLC is a Sell
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.